Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Bacares

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|April 2, 2015
BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell lineArianne Morrison, Yvonne Chekaluk, Ruben Bacares, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
A Rapid and Reliable Test for <i>BRCA1</i> Promoter Hypermethylation in Paraffin Tissue Using PyrosequencingRuben Bacares, Robert Soslow, Narciso Olvera, et al.
Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.
Breast Cancer Research and Treatment|August 25, 2011
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levelsLiying Zhang, Lishi Chen, Ruben Bacares, et al.
Mutation Research|March 17, 2015
The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutationLiying Zhang, Alexander Xiao, Jeanine Ruggeri, et al.
Plos One|November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice SiteZarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
Human Pathology|October 15, 2014
Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stageJiqing Ye, Yi Zhou, Martin R Weiser, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia, Liying Zhang, Moshe Shike, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|April 2, 2015
BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell lineArianne Morrison, Yvonne Chekaluk, Ruben Bacares, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
A Rapid and Reliable Test for <i>BRCA1</i> Promoter Hypermethylation in Paraffin Tissue Using PyrosequencingRuben Bacares, Robert Soslow, Narciso Olvera, et al.
Mutation Research|December 17, 2008
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutationLiying Zhang, Ruben Bacares, Sherry Boyar, et al.
Breast Cancer Research and Treatment|August 25, 2011
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levelsLiying Zhang, Lishi Chen, Ruben Bacares, et al.
Mutation Research|March 17, 2015
The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutationLiying Zhang, Alexander Xiao, Jeanine Ruggeri, et al.
Plos One|November 24, 2016
CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice SiteZarina Yelskaya, Ruben Bacares, Erin Salo-Mullen, et al.
Human Pathology|October 15, 2014
Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stageJiqing Ye, Yi Zhou, Martin R Weiser, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiencyJinru Shia, Liying Zhang, Moshe Shike, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Pageof 1